Skip to content

Gastroesophageal Reflux Disease (GERD) Before and After Gastric Bypass

The Impact of Gastric Bypass on Gastroesophageal Reflux Disease in Patients With Morbid Obesity: a Prospective Study Based on Montreal Consensus

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00951093
Enrollment
53
Registered
2009-08-04
Start date
2007-03-31
Completion date
2012-12-31
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux Disease, Morbid Obesity

Keywords

GERD, Gastric bypass

Brief summary

The hypothesis of this study was that gastric bypass (GBP) ameliorates gastroesophageal reflux disease (GERD) in morbidly obese patients.

Detailed description

The investigators studied the impact of this surgical procedure on GERD in patients with morbid obesity. Esophageal syndromes were evaluated according to the Montreal Consensus, where troublesome symptoms were defined as score ≥ 2 on a validated questionnaire of symptoms for Portuguese language along with esophageal syndromes with injury assessed through upper endoscopy. Esophageal acid exposure was determined through 24h pH monitoring. Increased acid exposure was characterized when total esophageal pH \< 4 for at least 4% of the total monitoring time.

Interventions

PROCEDUREGastric bypass

Open Silastic® ring Roux-en Y gastric bypass was performed through an upper midline incision. A gastric pouch was created by dividing the stomach with a 10-cm stapler from the lesser curvature (7 cm vertically from the cardia) to 1 cm to the left of the Hiss angle. The estimated volume of the gastric pouch was 20 to 30 ml that was banded with a 6.5 cm long Silastic® ring. A gastrojejunal anastomosis was performed with two-layers hand sewn absorbable suture over a 1.2 cm bougie distal to the ring, keeping an alimentary limb with 100 cm in length, and a biliopancreatic limb ranging 60 and 80 cm.

Sponsors

Clinica Gastrobese
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Morbid obesity * Acceptance to undergo open gastric bypass

Exclusion criteria

* Prior gastroesophageal surgery * Achalasia

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Presenting Reflux SymptomsBefore GBP, 6 months after GBP and 39 months after GBPPrevalence of typical reflux syndrome according to the Montreal Consensus. This Consensus institutes that GERD can be outlined when troublesome symptoms and/or complications induced by reflux of the gastric content back to the esophagus are present. In order to assess such troublesome symptoms a validated questionnaire translated into Portuguese language was used.
Number of Participants With Esophageal InjuryBefore GBP, 6 months after GBP and 39 months after GBPSyndromes with esophageal injury were represented exclusively by the presence of reflux esophagitis
Number of Participants With Gastroesophageal Reflux Disease (GERD)Before GBP, 6 months after GBP and 39 months after GBPPrevalence of GERD in patients characterized according to troublesome symptomatic syndromes assessed through a validated questionnaire based on the Montreal Consensus.
Total Esophageal Acid Exposure at 24h pH MonitoringBefore GBP, 6 months after GBP and 39 months after GBPEsophageal acid exposure was measured through 24h pH monitoring. During the entire period, esophageal pH was measured and recorded as the percent of time pH was below 4.
Esophageal Acid Exposure at 24h pH Monitoring in Upright PositionBefore GBP, 6 months after GBP and 39 months after GBPEsophageal acid exposure was measured through 24h pH monitoring. Esophageal pH was measured and recorded as the percent of time pH was below 4 while participant in upright position
Esophageal Acid Exposure at 24h pH Monitoring in Supine PositionBefore GBP, 6 months after GBP and 39 months after GBPEsophageal acid exposure was measured through 24h pH monitoring. Esophageal pH was measured and recorded as the percent of time pH was below 4 while participant in supine position
Number of Participants With Increased Acid ExposureBefore GBP, 6 months after GBP and 39 months after GBPIncreased Acid Exposure occurs when esophageal pH is \<4 for a period longer than 4% of the total test time on a 24h pH monitoring.

Countries

Brazil

Participant flow

Recruitment details

126 consecutive patients were assessed on site (Gastrobese Clinic) between March and October 2007, 94 met the criteria. 8 patients were lost to follow-up, 4 before and 4 after GBP. Out of those, 15 were lost to follow-up and 18 refused to follow through, resulting on the actual 53 patients.

Participants by arm

ArmCount
Patients Assessed for GERD
Patients who had an open gastric bypass were assessed for GERD before and after surgery.
53
Total53

Baseline characteristics

CharacteristicPatients Assessed for GERD
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
53 Participants
Age, Continuous38.26 years
STANDARD_DEVIATION 11.56
Region of Enrollment
Brazil
53 participants
Sex: Female, Male
Female
38 Participants
Sex: Female, Male
Male
15 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Esophageal Acid Exposure at 24h pH Monitoring in Supine Position

Esophageal acid exposure was measured through 24h pH monitoring. Esophageal pH was measured and recorded as the percent of time pH was below 4 while participant in supine position

Time frame: Before GBP, 6 months after GBP and 39 months after GBP

ArmMeasureValue (MEDIAN)
Before GBPEsophageal Acid Exposure at 24h pH Monitoring in Supine Position1.8 percentage of time
6 Months After GBPEsophageal Acid Exposure at 24h pH Monitoring in Supine Position0.5 percentage of time
39 Months After GBPEsophageal Acid Exposure at 24h pH Monitoring in Supine Position0.0 percentage of time
p-value: 0.001Wilcoxon (Mann-Whitney)
Primary

Esophageal Acid Exposure at 24h pH Monitoring in Upright Position

Esophageal acid exposure was measured through 24h pH monitoring. Esophageal pH was measured and recorded as the percent of time pH was below 4 while participant in upright position

Time frame: Before GBP, 6 months after GBP and 39 months after GBP

ArmMeasureValue (MEDIAN)
Before GBPEsophageal Acid Exposure at 24h pH Monitoring in Upright Position5.9 percentage of time
6 Months After GBPEsophageal Acid Exposure at 24h pH Monitoring in Upright Position0.8 percentage of time
39 Months After GBPEsophageal Acid Exposure at 24h pH Monitoring in Upright Position0.1 percentage of time
p-value: <0.001Wilcoxon (Mann-Whitney)
Primary

Number of Participants Presenting Reflux Symptoms

Prevalence of typical reflux syndrome according to the Montreal Consensus. This Consensus institutes that GERD can be outlined when troublesome symptoms and/or complications induced by reflux of the gastric content back to the esophagus are present. In order to assess such troublesome symptoms a validated questionnaire translated into Portuguese language was used.

Time frame: Before GBP, 6 months after GBP and 39 months after GBP

ArmMeasureValue (NUMBER)
Before GBPNumber of Participants Presenting Reflux Symptoms31 participants
6 Months After GBPNumber of Participants Presenting Reflux Symptoms8 participants
39 Months After GBPNumber of Participants Presenting Reflux Symptoms5 participants
p-value: <0.001Friedman´s test
Primary

Number of Participants With Esophageal Injury

Syndromes with esophageal injury were represented exclusively by the presence of reflux esophagitis

Time frame: Before GBP, 6 months after GBP and 39 months after GBP

ArmMeasureValue (NUMBER)
Before GBPNumber of Participants With Esophageal Injury24 participants
6 Months After GBPNumber of Participants With Esophageal Injury17 participants
39 Months After GBPNumber of Participants With Esophageal Injury10 participants
p-value: 0.002Friedman´s test
Primary

Number of Participants With Gastroesophageal Reflux Disease (GERD)

Prevalence of GERD in patients characterized according to troublesome symptomatic syndromes assessed through a validated questionnaire based on the Montreal Consensus.

Time frame: Before GBP, 6 months after GBP and 39 months after GBP

ArmMeasureValue (NUMBER)
Before GBPNumber of Participants With Gastroesophageal Reflux Disease (GERD)34 participants
6 Months After GBPNumber of Participants With Gastroesophageal Reflux Disease (GERD)21 participants
39 Months After GBPNumber of Participants With Gastroesophageal Reflux Disease (GERD)12 participants
p-value: <0.001Friedman´s test
Primary

Number of Participants With Increased Acid Exposure

Increased Acid Exposure occurs when esophageal pH is \<4 for a period longer than 4% of the total test time on a 24h pH monitoring.

Time frame: Before GBP, 6 months after GBP and 39 months after GBP

ArmMeasureValue (NUMBER)
Before GBPNumber of Participants With Increased Acid Exposure31 participants
6 Months After GBPNumber of Participants With Increased Acid Exposure16 participants
39 Months After GBPNumber of Participants With Increased Acid Exposure9 participants
p-value: <0.001Friedman´s test
Primary

Total Esophageal Acid Exposure at 24h pH Monitoring

Esophageal acid exposure was measured through 24h pH monitoring. During the entire period, esophageal pH was measured and recorded as the percent of time pH was below 4.

Time frame: Before GBP, 6 months after GBP and 39 months after GBP

ArmMeasureValue (MEDIAN)
Before GBPTotal Esophageal Acid Exposure at 24h pH Monitoring5.1 percentage of time
6 Months After GBPTotal Esophageal Acid Exposure at 24h pH Monitoring1.2 percentage of time
39 Months After GBPTotal Esophageal Acid Exposure at 24h pH Monitoring0.1 percentage of time
p-value: <0.02Wilcoxon (Mann-Whitney)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026